Soileau MJ, Aldred J, Budur K, Fisseha N, Fung VSc, Jeong A, Kimber TE, Klos K, Litvan I, O'Neill D, et al. Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson's disease: a randomised, double-blind, active-controlled, phase 3 trial. Lancet Neurol. 2022;21(12):1099-1109.